National Director, 21st Century Oncology Translational Research Consortium
Dr Finkelstein is a Board Certified Radiation Oncologist and National Director, 21st Century Oncology Translational Research Consortium (TRC); Adjunct Associate Professor, Translational Genomics Research Institute (TGEN); Director, TRC Animal Radiation-Imaging-Immunotherapy Experimental Laboratory (ARIEL); National Principal Investigator, Radiation Therapy Oncology Group (RTOG)-21C; and Executive Director, Arizona Cancer Research Alliance (ACRA)
Dr Finkelstein received his MD from the University of Michigan in 1997 graduating cum laude eruditionis causa. He joined the National Cancer Institute in 1999 and completed both Surgical Oncology and Clinical Immunotherapy Fellowship in 2004. Following completion of Chief Resident in Radiation Oncology at MCC, he joined the 21st Century Oncology Translational Research Consortium (TRC) and was appointed its Director in 2011. In that role, he is responsible for advancing patient access to novel, advanced cancer care.
Dr Finkelstein has published journal articles and book chapters resulting in 2000+ reference citations in the literature and gives national and international lectures on utilizing “cutting edge” radiation driven, personalized systemic therapy. He has received numerous prestigious awards across specialties, including but not limited to RSNA Roentgen Award, American College of Surgeons, First Place for Clinical, and iSBTc 18th Presidential Award.